4d
GlobalData on MSNGenentech eyes lupus market for Gazyva with positive Phase III data readoutRoche’s subsidiary Genentech has shared positive Phase III data with the US Food and Drug Administration (FDA) as the company ...
A study showed notable differences in bone mineral density between children on steroids and those not on steroids, with 84% ...
Obinutuzumab, a humanized type II anti-CD20 monoclonal antibody, provided significantly better renal responses than placebo in a phase 2 trial involving patients with lupus nephritis receiving ...
Here’s how it works. Space can be a wondrous place, and we've got the pictures to prove it! Take a look at our favorite space pictures here, and if you're wondering what happened to today in ...
The investment firm is acquiring Mitsubishi Tanabe Pharma in a deal valued at $3.3 billion. Elsewhere, Bausch + Lomb hasn’t ...
Atherosclerosis cardiovascular disease (ASCVD)-related mortality is higher in patients with lupus nephritis (LN) compared ...
Dr Janine Zee-Cheng, a board-certified paediatrician in Indiana, told HuffPost that sometimes a child will come in with a headache, a stomachache and a fever and test positive for strep without ever ...
Dialysis is the use of a special machine to remove waste and excess fluid from the body when the kidney is not functioning properly. Patients and caretakers told this publication at the dialysis ...
Kidney inflammation caused by SLE is referred to as lupus nephritis (LN), and it is estimated that between 40% and 50% of all SLE patients will develop LN that requires treatment over the course ...
4d
SB Nation on MSNRodolfo Bellato celebrates UFC 312 return after health scare: ‘I was peeing blood’Rodolfo Bellato wants to regain momentum in the octagon after a scary diagnosis sidelined him for more than a year.
including lupus nephritis and autoimmune cytopenias. It is due to advance into phase 3 later this year for IgAN, a rare autoimmune kidney disorder and a leading cause of kidney failure ...
Several risk tools can accurately predict individual baseline risks of adverse events in people with chronic kidney disease. Here, the authors examine methods of assessing risk and discuss risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results